New Hot Topic — The Region 4 Stork (R4S) Collaborative Project, Part 3: Post-Analytical Interpretive Tools
In Part 3 of this six-part presentation, Piero Rinaldo, M.D., Ph.D., explains how to use the post-analytical interpretive tools in newborn screening.
Read More
Peer-reviewed articles — Week of June 17
Each Monday a list of the latest peer-reviewed articles by members of Mayo Clinic’s Department of Laboratory Medicine and Pathology will be published here. This week there are four articles posted. Read more for links to the abstracts.
Read More
New Hot Topic: HLA-B*5801 Testing for Allopurinol Severe Cutaneous Adverse Reactions
Allopurinol is a widely used treatment for hyperuricemia-related diseases, but the drug carries the risk of severe adverse cutaneous drug reactions including Stevens Johnson syndrome and toxic epidermal necrolysis, which are considered medical emergencies as they can result in fatalities. This hypersensitivity reaction to allopurinol has been linked to the HLA-B*5801 allele, which is present in both susceptible and healthy individuals at frequencies that vary by ethnicity. Pretreatment testing for HLA-B*5801, in either blood or saliva, can help identity those at risk for these complications.
Read More
Peer-reviewed articles — Week of June 10
Each Monday a list of the latest peer-reviewed articles by members of Mayo Clinic’s Department of Laboratory Medicine and Pathology will be published here. This week there are two articles posted. Read more for links to the abstracts.
Read More
New Hot Topic — The Region 4 Stork (R4S) Collaborative Project, Part 2: First Generation Productivity Tools
In Part 2 of this six-part presentation, Piero Rinaldo, M.D., Ph.D., demonstrates the use of first generation productivity tools in newborn screening.
Read More
New Hot Topic — The Region 4 Stork (R4S) Collaborative Project, Part 1: Laboratory Quality Improvement of Newborn Screening
In Part 1 of this six-part presentation, Piero Rinaldo, M.D., Ph.D., introduces the concept of disease ranges for improved identification of abnormal newborn screening results.
Read More
|